AZD1386: Clinical Trials

7 trials of AZD1386, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Completed 6, Terminated 1

Follow AZD1386: new trials by email Literature Review of AZD1386 trials Research Report on AZD1386

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers
AZD1386, Placebo for AZD1386, Naproxen - Healthy Volunteers
Phase 1TerminatedAstraZeneca112009-08-012010-12-10
Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386
AZD1386 - Pain
Phase 1CompletedAstraZeneca62009-01-012009-04-28
Esophageal Hypersensitivity Study in Healthy Volunteers
AZD1386, Placebo - Pain, Esophageal Sensitivity
Phase 1CompletedAstraZeneca452008-06-012009-08-28
Formulation and Food Effect Study of AZD1386 in Healthy Volunteers
AZD1386 - Pharmacokinetics
Phase 1CompletedAstraZeneca122008-06-012010-12-10
AZD1386 Japanese Multiple Ascending Dosing Study
AZD1386, Placebo - Chronic Pain
Phase 1CompletedAstraZeneca322008-06-012009-09-30
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386
AZD1386, Placebo - Chronic Pain
Phase 1CompletedAstraZeneca692008-02-012010-12-10
Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)
AZD1386, Placebo - Capsaicin Evoked Pain, Heat Sensitivity
Phase 1CompletedAstraZeneca362008-01-012008-06-06

Conditions studied

Pain (3)  ·  Chronic Pain (2)  ·  Gastroesophageal Reflux (1)

Sponsors

AstraZeneca (7)

Countries

United Kingdom (3)  ·  Denmark (1)  ·  Japan (1)  ·  Sweden (1)

Top investigators

Rolf Karlsten (2)  ·  Agneta Berg (1)  ·  Dr. Tania Hugo (1)  ·  Klaus Francke, MD (1)  ·  Marie Sundin (1)  ·  Peter Funch-Jensen, MD, PhD (1)  ·  Raj Chetty, MD (1)  ·  Ray Chetty (1)  ·  Richard Leff (1)  ·  Shunji Matsuki (1)

Results publications

PMID 21410733

NIH funding

2008 (1)